
VOGLIREX-VM 2.2
Glimepiride, Metformin HCl (SR) & Voglibose Tablets

Glimepiride, Pioglitazone & Metformin HCl (SR) Tablets
Triple-action anti-diabetic formulation targeting peripheral insulin resistance and sustained glycemic control.
2 mg + 15 mg + 500 mg
Strip of 10 Tablets
Rs. 110.00
Schedule H Rx
Each film-coated tablet contains:
Type 2 Diabetes Mellitus with insulin resistance
Glycemic control in difficult-to-manage cohorts
REXPRIDE GMP2 combines Glimepiride, Pioglitazone (PPAR-gamma agonist addressing peripheral insulin sensitivity), and Metformin HCl SR for patients requiring comprehensive metabolic stabilization.
Standard Adult / Pediatric Regimen:
Swallowed whole with breakfast or first main meal, as directed by physician.
Disclaimer: Dosage must be strictly adjusted by treating physicians based on clinical severity, renal clearance, and body weight.
10 × 10 Alu-Alu Strip in box
Store in a dry place at a temperature not exceeding 25°C
RexCure Pharmaceuticals Pvt. Ltd.
Hyderabad, Telangana
Healthcare practitioners and hospital pharmacies may request detailed product dossiers, bio-equivalence data, or clinic samples.
Contact Medical DeskDrug Law Compliance
Marketed under Drugs and Cosmetics Act, 1940 and Rules thereunder. Distributed exclusively through licensed pharmaceutical wholesalers and pharmacies.
Glimepiride, Metformin HCl (SR) & Voglibose Tablets